Abstract
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title: Patent Annotations
Volume: 1 Issue: 1
Author(s): Bentham Science Publisher
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Bentham Science Publisher , Patent Annotations, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2007; 1 (1) . https://dx.doi.org/10.2174/187221407779814606
DOI https://dx.doi.org/10.2174/187221407779814606 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
10
Related Articles
-
Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis
Current Pharmaceutical Design Preface
Current Radiopharmaceuticals Polyisoprenylated Cysteinyl Amide Inhibitors: A Novel Approach to Controlling Cancers with Hyperactive Growth Signaling
Current Medicinal Chemistry Peptide-Mediated Delivery of Therapeutic and Imaging Agents Into Mammalian Cells
Current Pharmaceutical Design In situ Generated <sup>212</sup>Pb-PSMA Ligand in a <sup>224</sup>Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells
Current Radiopharmaceuticals In Vivo Bio-imaging Using Chlorotoxin-based Conjugates
Current Pharmaceutical Design Tribbles-Related Protein Family Members as Regulators or Substrates of the Ubiquitin-Proteasome System in Cancer Development
Current Cancer Drug Targets Smart Polymers for Controlled Delivery of Proteins and Peptides: A Review of Patents
Recent Patents on Drug Delivery & Formulation Anticancer Potential of Dietary Natural Products: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry FDG-PET/CT and SPECT/CT in Oncology
Current Medical Imaging Intractable Cancers: The Many Faces of Multidrug Resistance and the Many Targets it Presents for Therapeutic Attack
Current Drug Targets Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Current Drug Safety Synthesis and Biological Evaluation of Triazole-Vanillin Molecular Hybrids as Anti-Cancer Agents
Current Bioactive Compounds Circulating Tumor Cells (CTCs) as a Liquid Biopsy Material and Drug Target
Current Drug Targets IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets Gene Therapy of Cancer Based on Interleukin 12
Current Gene Therapy Editorial [Hot Topic: Imaging of Tumor Characteristics for Tailored Therapy (Executive Editor: Erik de Vries)]
Current Pharmaceutical Design Cognitive Impacts of Estrogen Treatment in Androgen-Deprived Males: What Needs to be Resolved
Current Neuropharmacology Targeting DNA Topoisomerase I with Non-Camptothecin Poisons
Current Medicinal Chemistry Bioinformatic Screening of Autoimmune Disease Genes and Protein Structure Prediction with FAMS for Drug Discovery
Protein & Peptide Letters